In experimental rhabdomyolysis-induced AKI, the aminoguanidine agmatine activated Nrf2 and reduced renal inflammation, decreasing TNF-α, IL-1β, and NF-κB [173]. This evidence concerns the gene NFKB1 and acute kidney injury.